Paramount and Skydance are back on with a preliminary merger deal, WSJ reports

by OverviewFX | Jul 3, 2024 | Stocks

The on-again, off-again courtship between Shari Redstone, Paramount Global Inc. and Skydance Media is back on, after the three sides reportedly have reached a preliminary merger deal.

Intuitive Machines’ stock rockets as next moon mission approaches

by OverviewFX | Jul 2, 2024 | Stocks

Shares of Intuitive Machines Inc. surged 12% Tuesday as the space-exploration company edges closer to its next mission to the moon.

Eli Lilly’s Alzheimer’s drug wins FDA approval

by OverviewFX | Jul 2, 2024 | Stocks

An Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the medication’s bumpy ride through the U.S. regulatory process and adding a second new treatment option for patients in earlier stages of the disease.

I’m 73 and have $930,000 in my IRA. Should I wait for the market to go down before I do a Roth conversion?

by OverviewFX | Jul 2, 2024 | Stocks

Trying to time with the market is usually a fool’s errand, but there are several schools of thought about how to best do a conversion.

Annovis Bio’s stock rockets 119% after reporting positive data in Parkinson’s disease trial

by OverviewFX | Jul 2, 2024 | Stocks

The stock is on track for its best performance since May 21, 2021, when it gained 127%.

Novo Nordisk, Eli Lilly singled out by Biden, Sanders over drug prices

by OverviewFX | Jul 2, 2024 | Stocks

Shares of Novo Nordisk and Eli Lilly & Co. dropped early Tuesday after President Joe Biden and Sen. Bernie Sanders took aim at obesity and diabetes drug prices in a USA Today opinion piece.